Notice of Correction to Funds Available and Anticipated Number of Awards for RFA-FD-14-009 "Dissolution Methods for Suspension and Emulsion Ocular Drug Products (U01)"

Notice Number: NOT-FD-14-005

Key Dates
Release Date: April 9, 2014

Related Announcements
RFA-FD-14-009

Issued by
U.S. Food and Drug Administration

Purpose

The purpose of this Notice is to correct the Funds Available and Anticipated Number of Awards for RFA-FD-14-009

Now Reads:


Funds Available and Anticipated Number of Awards

The FDA and partner components intend to commit an estimated total of $250,000 to fund 1 award.


Should Read:


Funds Available and Anticipated Number of Awards

The FDA and partner components intend to commit an estimated total of $250,000 per award.  Up to 2 awards may be funded.


Inquiries

Please direct all inquiries to:

Gladys Melendez (Bohler)
Food and Drug Administration (FDA)
Telephone: 301-515-0642
Email: gladys.bohler@fda.hhs.gov